Abstract
Dipeptidyl peptidase IV (DP IV, EC 3.4.14.3) is a transmembrane type II glycoprotein present on most mammalian cells 1,2.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fleischer, B. (1994) CD26: a surface protease involved in T-cell activation../. ImnumoL 15, 180–184.
Morimoto, C. Schlossman. S. F. 11994) A key costimulatory molecule on CD4 memory T cells. The Immunologist 2, 4- -7.
Bühling, F., Junker, U., Reinhold, D.. Neubert, K., Jäger, L. Ansorge, S. (1995) Functional role of CD26 on human B lymphocytes. Immunol. Lett. 45, 47–51.
Bühling, F.. Kunz. D., Reinhold, D., Ulmer, A. J., Ernst, M., Flad, H.-D. Ansorge, S. (1994) Expression and functional role ofdipeptidyl peptidase IV on human natural killer cells. Nat. Immun. 13, 270–279.
Yaron, A. Naider, F. (1993) Proline-dependent structural and biological properties of peptides and proteins. Olt. Rev Biochem. Mol. Biol. 28, 31–81.
Ulmer, A. J., Mattern, T., Feller, A. C., Heymann, E. Flad, H.–D. (1990) CD26 antigen is a surface Dipeptidyl peptidase IV (DPPIV) as characterised by monoclonal antibodies clone TII–l9–4–7 and 4ELICl. Scand. J. Immunol. 31, 429 – 435.
Hegen, M., Niedobitek, C., Klein, C. E., Stein, H. Fleischer, B. (1990) The T cell triggering molecule Tp103 is associated with Dipeptidyl aminopeptidase IV activity. J. Immunol. 144, 2908–2914.
Mattern, T., Flad, H.-D., Feller, A. C., Heymann, E. Ulmer, A. J. (1989) Anti-DPP-IV and anti-Tal but not IOT 15 should be clustered in CDw26. In: Leukocyte Typing IV. Knapp, W., Dörken, B., Gilks, W. R., Rieber, E. P., Schmidt, R. E., Stein, H. Von Dem Borne, A. E. G. K. (Eds.), 416.
Kameoka, J., Tanaka, T., Nojima, Y., Schlossman, S. F. Morimoto, C. (1993) Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 261, 466–469
Morimoto, C., Torimoto, Y., Levinson, G., Rudd, C. E., Schrieber, M., Dang, N. H., Letvin, N. L. Schlossman, S. F. (1989) 1F7, a novel cell surface molecule, involved in helper function of CD4 cells. J. Immunol. 143, 3430–3439.
Fleischer, B., Sturm, E., De Vries, J. E. Spits, H. (1988) Triggering of cytotoxic T lymphocytes and NK cells via the Tp103 pathway is dependent on the expression of the T cell receptor’CD3 complex..1 Immunol. 141, 1103–1107.
Hegen, M., Camerini, D. Fleischer, B. (1993) Function of dipeptidyl peptidase IV (CD26, Tp103) in transfected human T cells. Cell. Immunol. 146, 249–260.
Ansorge, S., Schön, E. Kunz, D. (1991) Membrane-bound peptidases of lymphocytes: Functional imphcations. Biomed. Biochem. Acta 50, 799–807.
Schön, E., Demuth. U. H., Barth, A. Ansorge, S. (1984) Dipeptidyl peptidase IV of human lymphocytes. Evidence for specific hydrolysis of glycylprolin in T-lymphocytes. Biochem. J. 223, 255–258.
Schön. E., Eichmann, E., Grunow, R.. Jahn, S., Kiessig, S. T., Volk, H. D. Ansorge, S. (1986) Dipeptidyl peptidase IV in human T lymphocytes. An approach to the role of a membrane peptidase in the immune system. Biomed. Biochem. Acta 45, 1523–1528.
Dang, N. H., Torimoto, Y., Deusch, K., Schlossman, S. F. Morimoto, C. (1990) Comitogenic effect of solid-phase immobilized anti-I F7 on human CD4 T cell activation via CD3 and CD2 pathways,.1. Immunol. 144, 4092–4100.
Dang, N. H., Torimoto, Y., Sugita, K., Daley, J. F., Show, P., Porado, C., Schlossman, S. F. Morimoto, C (1990) Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation. J. Imnumol. 145, 3963.
Dang, N. H., Torimoto, Y., Shimamura, K., Tanaka, T., Daley, J. F.. Schlossman, S F Morimoto, C. (1991) 1F7 (CD26): A marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation. J. Immunol 147, 2825–2832.
Schön, E., Born. I., Demuth, H.-U., Faust, J., Neubert, K., Stemmetzer, T., Barth, A. Ansorge, S. (1991) Dipeptidyl peptidase IV in the immune system. Effects of specific enzyme inhibitors on activity of dipeptidyl peptidase IV and proliferation of human lymphocytes. Biol. Chem. Hoppe Sevier 372, 305–311.
Schön. E., Demuth, H.-U., Eichmann, E., Horst, H.-J., Körner, 1.-.1., Kopp, J.. Mattem, T., Neubert, K., Noll, F., Ulmer, J. A., Barth, A. Ansorge, S. (1989) Dipeptidyl peptidase IV in human T lymphocytes Impaired induction of interleukin 2 and gamma interferon due to specific inhibition of dipeptidyl peptidase IV. Scand. J. Immunol. 29, 127–132.
Schön, E., Jahn, S., Kiessig, S. T., Demuth, H.-U., Neubert, K., Barth, A., von Baehr, R. Ansorge. S. (1987) The role of dipeptidyl peptidase IV in human T lymphocyte activation. inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro. Eue J. Immunol. 17, 1821–1826.
Torimoto, Y., Dang, N. H., Vivier, E., Tanaka, T.. Schlossman, S. F. Morimoto.. C (1991) Coassocìation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes.1. Immunol_ 147. 2514–2517.
Torimoto, Y., Dang, N. H., Tanaka, T., Prado, C., Schlossman, S. F Morimoto, C. (1992) Biochemical characterization of CD26 (dipeptidyl peptidase IV): Functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies. Mol. Immunol. 29, 183–192.
Schön, E., Eichmann, E., Jahn, S., Kopp, J., Volk, H. D. Ansorge, S. (1988) On the role of dipeptidyl peptidase IV (DP IV) in thew immune system. Relations to the cell cycle and lymphokine production of activated lymphocytes. Biol. Zent. bl. 107, 141–149.
Reinhold, D., Bank. U., Bühling, F., Neubert, K., Mattem, T., Ulmer, A. J., Flad, H.-D. Ansorge, S. (1993) Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against Dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells and IL-2 and IL-6 production. Immunobiol. 188, 403–414.
Reinhold, D., Bank, U., Bühling, F., Kähne, T., Kunz, D., Faust, J., Neubert, K. Ansorge, S. (1994) Inhibitors of Dipeptidyl peptidase 1V (DP IV, CD26) specifically auppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells. bnmunobiology 192, 121–136.
Fleischer, B. (1987) A novel pathway of human T cell activation via a 103 kD T cell activation antigen. J. Immunol. 138, 1346–1350.
Ansorge, S., Bühling, F., Hoffmann, T., Kähne, T., Neubert, K. Reinhold, D. (1995) DP IV/CD26 on human lymphocytes: Functional roles in cell growth and cytokine regulation. In: Dipeptidyl Peptidase IV (CD26) in metabolism and the immune response. Fleischer, B. (Eds.)R.G. Landes Company, Austin, (10)163–184.
Kähne, T., Kröning, H., Thiel. U., Ulmer, A. J., Flad, H.-D. Ansorge, S. (1996) Alterations in structure and cellular localization of molecular forms of DP IV/CD26 during T cell activation. Cell Immunol. 170. 63–70.
Kähne, T. Ansorge, S. (1994) Non-radioaktive labelling and immunoprecipitation analysis of leukocyte surface proteins using different methods of protein biotinylation. J. Immunol. Methods 168, 209–218.
Kähne, T., Neubert. K. Ansorge, S. (1995) Enzymatic activity of DP IV/CD26 is involved in PMA-induced hyperphosphorylation of p56’°“.. Immunol. Lett. 46, 189–193.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Reinhold, D. et al. (1997). The Effect of Anti-CD26 Antibodies on DNA Synthesis and Cytokine Production (IL-2, IL-10 and IFN-γ) Depends on Enzymatic Activity of DP IV/CD26. In: Ansorge, S., Langner, J. (eds) Cellular Peptidases in Immune Functions and Diseases. Advances in Experimental Medicine and Biology, vol 421. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9613-1_19
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9613-1_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9615-5
Online ISBN: 978-1-4757-9613-1
eBook Packages: Springer Book Archive